President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareMake an AppointmentInfo for Healthcare ProfessionalsBillingPatient Portal
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team


Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications.

Joslin Diabetes Center undertakes diabetes research, clinical care, education and health and wellness programs on a global scale. We are dedicated to ensuring that people with diabetes live long, healthy lives, and we offer real progress in preventing and curing diabetes.

Joslin is an independent, nonprofit institution, academically affiliated with Harvard Medical School, and is recognized worldwide for driving innovative solutions in diabetes prevention, research, education, and care.

Upcoming Events


Published online by Joslin for the diabetes community worldwide, Speaking of Diabetes, features Joslin news, insights on diabetes, the latest on diabetes research and stories about people of all ages who live with Type 1 and Type 2 diabetes — information sourced from a single team of experts: the doctors, educators and researchers at the Joslin Diabetes Center.


Joslin Research Updates

Joslin Discovery May Hold Clues to Treatments that Slow Aging and Prevent Age-Related Chronic Disease

In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm (C. elegans) to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it—and might even lead to better cosmetics. Read the full story.


The Joslin 50 Year Medalist Program/Study